With decades of combined business experience in the life science and technology sectors, Norcliffe Capital provides more than capital to support our investments. We use our experience and expertise to select UK based growth companies in our specialist sectors and support them throughout their commercial journey.
Norcliffe Capital offers investors the opportunity to directly invest in individual private companies in the life science and disruptive technology sectors. Our investments typically target a return of 3-10x investment over 4 to 7 years with the aim of realising each investment, perhaps by the sale of the company or a listing on a stock exchange, to generate a capital return.